ClinConnect ClinConnect Logo
Search / Trial NCT05862688

A Cohort Study on Anti-microbial Stewardship in PICU

Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · May 8, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to improve the use of antibiotics in the Pediatric Intensive Care Unit (PICU) for children with infections. The goal is to ensure that patients receive the right antibiotics at the right time, which can help them recover faster and reduce the risk of complications, such as longer hospital stays or infections that are harder to treat. The trial will look into different strategies, like checking patients’ medical history, taking the right samples for testing, and adjusting treatments based on daily evaluations by healthcare teams.

To participate in this study, children must be admitted to the ICU for more than 48 hours. Unfortunately, those who are in the ICU for less than 48 hours won’t be eligible. Participants can expect to be part of a team effort that focuses on effective antibiotic use, which may improve their treatment outcomes. This trial is not yet recruiting patients, but it aims to gather valuable information that could help in managing infections more effectively in critically ill children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients admitted to the ICU for more than 48 hour
  • Exclusion Criteria:
  • Patients admitted to ICU less than 48 hours

About Children's Hospital Of Fudan University

The Children's Hospital of Fudan University is a leading pediatric healthcare institution in China, renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on conducting high-quality, ethically-driven studies that aim to improve pediatric care and treatment outcomes. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital leverages its robust infrastructure and expertise to facilitate groundbreaking clinical trials, ensuring the safety and well-being of child participants while contributing valuable insights to the global medical community.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported